-
MediWound NASDAQ:MDWD MediWound is a biopharmaceutical company that develops, manufactures and commercializes novel, cost effective, bio-therapeutic solutions for tissue repair and regeneration. Its strategy is centered around its validated enzymatic platform technology, focused on next-generation bio-active therapies for burn and wound care and biological medicinal products for tissue repair.
Location: Yavne, 8122745, Israel | Website: www.mediwound.com | Industry: Medicinal and Botanical Manufacturing | Sector: Manufacturing
Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
131.3M
Cash
29.22M
Avg Qtr Burn
-3.524M
Short % of Float
10.36%
Insider Ownership
19.76%
Institutional Own.
44.53%
Qtr Updated
06/30/24
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
NexoBrid Details Eschar removal, Thermal burns | Approved Quarterly sales | |
EscharEx Details Venous Leg Ulcers | Phase 3 Initiation | |
MW005 Details Cancer, Basal cell carcinoma, Non-melanoma skin cancer, Skin cancer | Phase 1/2 Update |